-
1
-
-
33646350017
-
Haemophilus influenzae type b immunization in infants in the United Kingdom: Effects of diphtheria/tetanus/acellular pertussis/Hib combination vaccine, significant prematurity, and a fourth dose
-
Berrington, J. E., A. J. Cant, J. N. Matthews, M. O'Keeffe, G. P. Spickett, and A. C. Fenton. 2006. Haemophilus influenzae type b immunization in infants in the United Kingdom: effects of diphtheria/tetanus/acellular pertussis/Hib combination vaccine, significant prematurity, and a fourth dose. Pediatrics 117:e717-e724.
-
(2006)
Pediatrics
, vol.117
-
-
Berrington, J.E.1
Cant, A.J.2
Matthews, J.N.3
O'Keeffe, M.4
Spickett, G.P.5
Fenton, A.C.6
-
2
-
-
30344447981
-
Diminished lung function, RSV infection, and respiratory morbidity in prematurely born infants
-
Broughton, S., R. Bhat, A. Roberts, M. Zuckerman, G. Rafferty, and A. Greenough. 2006. Diminished lung function, RSV infection, and respiratory morbidity in prematurely born infants. Arch. Dis. Child. 91:26-30.
-
(2006)
Arch. Dis. Child.
, vol.91
, pp. 26-30
-
-
Broughton, S.1
Bhat, R.2
Roberts, A.3
Zuckerman, M.4
Rafferty, G.5
Greenough, A.6
-
3
-
-
78449263033
-
Reduced IgG antibody response to Neisseria meningitidis type C (MenC) immunisation in significantly preterm UK infants, ES2
-
Abstr.
-
Cant, A., J. E. Berrington, A. C. Fenton, Q. Zang, and A. Finn. 2005. Reduced IgG antibody response to Neisseria meningitidis type C (MenC) immunisation in significantly preterm UK infants, ES2. Abstr. 23rd Annu. Meet. Eur. Soc. Paediatr. Infect. Dis. (ESPID), 18 to 20 May 2005, Valencia, Spain.
-
(2005)
23rd Annu. Meet. Eur. Soc. Paediatr. Infect. Dis. (ESPID), 18 to 20 May 2005, Valencia, Spain
-
-
Cant, A.1
Berrington, J.E.2
Fenton, A.C.3
Zang, Q.4
Finn, A.5
-
5
-
-
0004059713
-
-
Department of Health Immunisation against Infectious Diseases Department of Health Immunisation against Infectious Diseases, London, United Kingdom
-
Department of Health Immunisation against Infectious Diseases. 1996. The green book. Department of Health Immunisation against Infectious Diseases, London, United Kingdom.
-
(1996)
The Green Book
-
-
-
6
-
-
13444249859
-
Immunogenicity, safety and tolerability of heptavalent pneumococcal conjugate vaccine administered at 3, 5 and 11 months post-natally to pre- and full-term infants
-
Esposito, S., L. Pugni, S. Bosis, A. Proto, L. Cesati, C. Bianchi, C. Cimino, F. Mosca, and N. Principi. 2005. Immunogenicity, safety and tolerability of heptavalent pneumococcal conjugate vaccine administered at 3, 5 and 11 months post-natally to pre- and full-term infants. Vaccine 23:1703-1708.
-
(2005)
Vaccine
, vol.23
, pp. 1703-1708
-
-
Esposito, S.1
Pugni, L.2
Bosis, S.3
Proto, A.4
Cesati, L.5
Bianchi, C.6
Cimino, C.7
Mosca, F.8
Principi, N.9
-
7
-
-
33645536134
-
Immunogenicity and boosting after a reduced number of doses of a pneumococcal conjugate vaccine in infants and toddlers
-
Goldblatt, D., J. Southern, L. Ashton, P. Richmond, P. Burbidge, J. Tasevska, A. Crowley-Luke, N. Andrews, R. Morris, R. Borrow, K. Cartwright, and E. Miller. 2006. Immunogenicity and boosting after a reduced number of doses of a pneumococcal conjugate vaccine in infants and toddlers. Pediatr. Infect. Dis. J. 25:312-319.
-
(2006)
Pediatr. Infect. Dis. J.
, vol.25
, pp. 312-319
-
-
Goldblatt, D.1
Southern, J.2
Ashton, L.3
Richmond, P.4
Burbidge, P.5
Tasevska, J.6
Crowley-Luke, A.7
Andrews, N.8
Morris, R.9
Borrow, R.10
Cartwright, K.11
Miller, E.12
-
8
-
-
0035468744
-
Efficacy of pneumococcal conjugate vaccines and their effect on carriage and antimicrobial resistance
-
Klugman, K. P. 2001. Efficacy of pneumococcal conjugate vaccines and their effect on carriage and antimicrobial resistance. Lancet Infect. Dis. 1:85-91.
-
(2001)
Lancet Infect. Dis.
, vol.1
, pp. 85-91
-
-
Klugman, K.P.1
-
9
-
-
0029979631
-
Increased risk of reported pertussis and hospitalization associated with pertussis in low birth weight children
-
Langkamp, D. L., and J. P. Davis. 1996. Increased risk of reported pertussis and hospitalization associated with pertussis in low birth weight children. J. Pediatr. 128:654-659.
-
(1996)
J. Pediatr.
, vol.128
, pp. 654-659
-
-
Langkamp, D.L.1
Davis, J.P.2
-
10
-
-
27244440305
-
Changing epidemiology of invasive pneumococcal disease among older adults in the era of pediatric pneumococcal conjugate vaccine
-
and the Active Bacterial Core Surveillance Team
-
Lexau, C. A., R. Lynfield, R. Danila, T. Pilishvili, R. Facklam, M. M. Farley, L. H. Harrison, W. Schaffner, A. Reingold, N. M. Bennett, J. Hadler, P. R. Cieslak, C. G. Whitney, and the Active Bacterial Core Surveillance Team. 2005. Changing epidemiology of invasive pneumococcal disease among older adults in the era of pediatric pneumococcal conjugate vaccine. JAMA 294:2043-2051.
-
(2005)
JAMA
, vol.294
, pp. 2043-2051
-
-
Lexau, C.A.1
Lynfield, R.2
Danila, R.3
Pilishvili, T.4
Facklam, R.5
Farley, M.M.6
Harrison, L.H.7
Schaffner, W.8
Reingold, A.9
Bennett, N.M.10
Hadler, J.11
Cieslak, P.R.12
Whitney, C.G.13
-
11
-
-
14744304513
-
Use of conjugate pneumococcal vaccine by United Kingdom neonatal intensive care units
-
Moss, S. J., A. C. Fenton, and A. R. Gennery. 2005. Use of conjugate pneumococcal vaccine by United Kingdom neonatal intensive care units. Arch. Dis. Child. Fetal Neonatal Ed. 90:F187-F188.
-
(2005)
Arch. Dis. Child. Fetal Neonatal Ed.
, vol.90
-
-
Moss, S.J.1
Fenton, A.C.2
Gennery, A.R.3
-
12
-
-
77649260036
-
Immunogenicity of a heptavalent conjugate pneumococcal vaccine administered concurrently with a combination diphtheria, tetanus, five-component acellular pertussis, inactivated polio, and Haemophilus influenzae type b vaccine and a meningococcal group C conjugate vaccine at 2, 3, and 4 months of age
-
Moss, S. J., A. C. Fenton, J. Toomey, A. Grainger, R. Borrow, P. Balmer, J. Smith, and A. R. Gennery. 2010. Immunogenicity of a heptavalent conjugate pneumococcal vaccine administered concurrently with a combination diphtheria, tetanus, five-component acellular pertussis, inactivated polio, and Haemophilus influenzae type b vaccine and a meningococcal group C conjugate vaccine at 2, 3, and 4 months of age. Clin. Vaccine Immunol. 17:311-316.
-
(2010)
Clin. Vaccine Immunol.
, vol.17
, pp. 311-316
-
-
Moss, S.J.1
Fenton, A.C.2
Toomey, J.3
Grainger, A.4
Borrow, R.5
Balmer, P.6
Smith, J.7
Gennery, A.R.8
-
13
-
-
33845200674
-
Immunogenicity and induction of immunological memory of the heptavalent pneumococcal conjugate vaccine in preterm UK infants
-
Ruggeberg, J. U., C. Collins, P. Clarke, N. Johnson, R. Sinha, N. Everest, J. Chang, E. Stanford, P. Balmer, R. Borrow, S. Martin, M. J. Robinson, E. R. Moxon, A. J. Pollard, and P. T. Heath. 2007. Immunogenicity and induction of immunological memory of the heptavalent pneumococcal conjugate vaccine in preterm UK infants. Vaccine 25:264-271.
-
(2007)
Vaccine
, vol.25
, pp. 264-271
-
-
Ruggeberg, J.U.1
Collins, C.2
Clarke, P.3
Johnson, N.4
Sinha, R.5
Everest, N.6
Chang, J.7
Stanford, E.8
Balmer, P.9
Borrow, R.10
Martin, S.11
Robinson, M.J.12
Moxon, E.R.13
Pollard, A.J.14
Heath, P.T.15
-
14
-
-
0036188626
-
Efficacy, immunogenicity and safety of heptavalent pneumococcal conjugate vaccine in low birth weight and preterm infants
-
Shinefield, H., S. Black, P. Ray, B. Fireman, J. Schwalbe, and E. Lewis. 2002. Efficacy, immunogenicity and safety of heptavalent pneumococcal conjugate vaccine in low birth weight and preterm infants. Pediatr. Infect. Dis. J. 21:182-186.
-
(2002)
Pediatr. Infect. Dis. J.
, vol.21
, pp. 182-186
-
-
Shinefield, H.1
Black, S.2
Ray, P.3
Fireman, B.4
Schwalbe, J.5
Lewis, E.6
-
15
-
-
33749856304
-
Recommendations for the production and control of pneumococcal conjugate vaccines
-
WHO. World Health Organization, Geneva, Switzerland
-
WHO. 2005. Recommendations for the production and control of pneumococcal conjugate vaccines. WHO technical report series no. 927. World Health Organization, Geneva, Switzerland.
-
(2005)
WHO Technical Report Series No. 927
-
-
|